https://www.thebodypro.com/category/providing-quality-hiv-care/tag/news

The Latest

This Week in HIV Research: U.S. HIV Incidence Decreases; and Partner Services Most Effective Within 30 Days of Diagnosis Img

This Week in HIV Research: U.S. HIV Incidence Decreases; and Partner Services Most Effective Within 30 Days of Diagnosis

This week, a study estimates that the number of new HIV cases in the U.S. has steadily declined between 2003 and 2010, though the number of new cases remains around 40,000 a year.

This Week in HIV Research: Viral Load Testing With a USB Stick; and PEPFAR's Legacy Under Trump Img

This Week in HIV Research: Viral Load Testing With a USB Stick; and PEPFAR's Legacy Under Trump

This week, giving or receiving a viral load test using a special computer chip and a USB stick is possible, according to a proof-of-concept study.

This Week in HIV Research: Quitting Smoking Adds 5 Years to Life Expectancy, and Broadly Neutralizing Antibody Treatment Studied Further Img

This Week in HIV Research: Quitting Smoking Adds 5 Years to Life Expectancy, and Broadly Neutralizing Antibody Treatment Studied Further

This week, a study finds that quitting smoking could raise the life expectancy of people living with HIV by five years.

This Week in HIV Research: Vitamin D May Protect Against HIV; and Protease Inhibitor Monotherapy Img

This Week in HIV Research: Vitamin D May Protect Against HIV; and Protease Inhibitor Monotherapy

This week, a study examines how two precursor forms of vitamin D may help protect against HIV infection. Another study supports the idea of protease inhibitor monotherapy for some individuals living with HIV.

This Week in HIV Research: Another Person Possibly Cured of HIV; and Long-Acting Rilpivirine Suppresses HIV in Rectal Tissue Img

This Week in HIV Research: Another Person Possibly Cured of HIV; and Long-Acting Rilpivirine Suppresses HIV in Rectal Tissue

This week, another individual may have been cured of HIV after receiving a stem-cell transplant from a donor with a natural resistance to the virus.

This Week in HIV Research: HIV-Related Inflammation May Be Irreversible; and Genetically Engineered T-Cells Resist HIV Img

This Week in HIV Research: HIV-Related Inflammation May Be Irreversible; and Genetically Engineered T-Cells Resist HIV

This week, a study finds that even if an HIV cure is achieved, the effects of HIV-related inflammation may be irreversible. In another study, researchers engineered CD4 cells that are resistant to HIV.

This Week in HIV Research: Improving Initiation of Treatment; and Analyzing Transmissions Among Intravenous Drug Users Img

This Week in HIV Research: Improving Initiation of Treatment; and Analyzing Transmissions Among Intravenous Drug Users

This week, a study in Africa finds that targeted training for health care workers greatly improves the number of patients who start treatment.

HIV Viral Load Testing Capacities Progress, Require Global Support, Multiple Partners to Reach 90-90-90 Goals Img

HIV Viral Load Testing Capacities Progress, Require Global Support, Multiple Partners to Reach 90-90-90 Goals

Four of seven sub-Saharan African countries followed by researchers over the last year and a half now can track the effectiveness of HIV treatment among all patients receiving it.

This Week in HIV Research: Reducing Cardiovascular Risk; and Monitoring Renal Function With PrEP Img

This Week in HIV Research: Reducing Cardiovascular Risk; and Monitoring Renal Function With PrEP

This week, a study in Europe finds that over 50% of individuals living with HIV who were at risk for cardiovascular disease were able to actively lower that risk.

This Week in HIV Research: Renal Impairment Raises Cardiovascular Disease Risk; and Statins Protect Against Cirrhosis Img

This Week in HIV Research: Renal Impairment Raises Cardiovascular Disease Risk; and Statins Protect Against Cirrhosis

This week, a study finds that people living with HIV who also have kidney disease have a higher risk of cardiovascular disease as well.